Human medicines European public assessment report (EPAR): Nplate, romiplostim, Date of authorisation: 04/02/2009, Revision: 30, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Zulvac BTV, bluetongue virus vaccine (inactivated) (multistrain: 1 strain out of a set of 3), Status: Authorised

Frequently asked questions about parallel distribution

Human medicines European public assessment report (EPAR): Ondexxya, andexanet alfa, Date of authorisation: 26/04/2019, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR): Mayzent, siponimod, Date of authorisation: 13/01/2020, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR): Ahzantive, aflibercept, Date of authorisation: 13/01/2025, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Firazyr, icatibant, Date of authorisation: 11/07/2008, Revision: 26, Status: Authorised

Human medicines European public assessment report (EPAR): Baiama, aflibercept, Date of authorisation: 13/01/2025, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Qinlock, ripretinib, Date of authorisation: 18/11/2021, Revision: 7, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Zulvac 1+8 Ovis, inactivated bluetongue serotype 1+8 vaccine, Status: Authorised